Literature DB >> 15382124

Overexpression of cholesterol transporter StAR increases in vivo rates of bile acid synthesis in the rat and mouse.

Shunlin Ren1, Phillip B Hylemon, Dalila Marques, Emily Gurley, Patricia Bodhan, Elizabeth Hall, Kaye Redford, Gregorio Gil, William M Pandak.   

Abstract

Bile acid synthesis (BAS) occurs mainly via two pathways: the "neutral" pathway, which is initiated by highly regulated microsomal CYP7A1, and an "acidic" pathway, which is initiated by mitochondrial CYP27A1. Previously, we have shown that overexpression of the steroidogenic acute regulatory protein (StAR), a mitochondrial cholesterol transport protein, increases bile acid biosynthesis more than 5-fold via the acidic pathway in primary rat hepatocytes. This observation suggests that mitochondrial cholesterol transport is the rate-limiting step of BAS via this pathway. The objective of this study was to determine the effect of increased StAR on rates of BAS in vivo. Overexpression of StAR and CYP7A1 were mediated via infection with recombinant adenoviruses. BAS rates were determined in chronic biliary-diverted rats and mice, and in mice with an intact enterohepatic circulation. The protein/messenger RNA levels of StAR and CYP7A1 increased dramatically following overexpression. Overexpression of StAR or CYP7A1 led to a similar 2-fold (P <.01) increase in BAS over up-regulated (approximately 2-fold) 3-day chronic biliary-diverted control rats. Additionally, overexpression of StAR led to more than 3- and 6-fold increases over controls in the rates of BAS in biliary-diverted and intact mice, respectively (P <.01). In conclusion, in both rats and mice in vivo, overexpression of StAR led to a marked increase in the rates of BAS initiated by delivery of cholesterol to mitochondria containing CYP27A1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15382124     DOI: 10.1002/hep.20382

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  29 in total

1.  25-Hydroxycholesterol-3-sulfate attenuates inflammatory response via PPARγ signaling in human THP-1 macrophages.

Authors:  Leyuan Xu; Shanwei Shen; Yongjie Ma; Jin Koung Kim; Daniel Rodriguez-Agudo; Douglas M Heuman; Phillip B Hylemon; William M Pandak; Shunlin Ren
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-01-24       Impact factor: 4.310

Review 2.  Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy.

Authors:  John Y L Chiang; Jessica M Ferrell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-27       Impact factor: 4.052

3.  Liver-specific transgenic expression of cholesteryl ester hydrolase reduces atherosclerosis in Ldlr-/- mice.

Authors:  Jinghua Bie; Jing Wang; Quan Yuan; Genta Kakiyama; Siddhartha S Ghosh; Shobha Ghosh
Journal:  J Lipid Res       Date:  2014-02-21       Impact factor: 5.922

Review 4.  Bile acids are nutrient signaling hormones.

Authors:  Huiping Zhou; Phillip B Hylemon
Journal:  Steroids       Date:  2014-05-10       Impact factor: 2.668

5.  25-Hydroxycholesterol-3-sulfate regulates macrophage lipid metabolism via the LXR/SREBP-1 signaling pathway.

Authors:  Yongjie Ma; Leyuan Xu; Daniel Rodriguez-Agudo; Xiaobo Li; Douglas M Heuman; Phillip B Hylemon; William M Pandak; Shunlin Ren
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

6.  Significance and mechanism of CYP7a1 gene regulation during the acute phase of liver regeneration.

Authors:  Lisheng Zhang; Xiongfei Huang; Zhipeng Meng; Bingning Dong; Steven Shiah; David D Moore; Wendong Huang
Journal:  Mol Endocrinol       Date:  2008-12-04

7.  Hepatic bile acid metabolism in the neonatal hamster: expansion of the bile acid pool parallels increased Cyp7a1 expression levels.

Authors:  Katie T Burke; Paul S Horn; Patrick Tso; James E Heubi; Laura A Woollett
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-23       Impact factor: 4.052

8.  Macrophage-specific transgenic expression of cholesteryl ester hydrolase significantly reduces atherosclerosis and lesion necrosis in Ldlr mice.

Authors:  Bin Zhao; Jingmei Song; Woon N Chow; Richard W St Clair; Lawrence L Rudel; Shobha Ghosh
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

9.  StAR overexpression decreases serum and tissue lipids in apolipoprotein E-deficient mice.

Authors:  Yanxia Ning; Leyuan Xu; Shunlin Ren; William M Pandak; Sifeng Chen; Lianhua Yin
Journal:  Lipids       Date:  2009-04-17       Impact factor: 1.880

10.  Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition.

Authors:  Genta Kakiyama; Dalila Marques; Rebecca Martin; Hajime Takei; Daniel Rodriguez-Agudo; Sandra A LaSalle; Taishi Hashiguchi; Xiaoying Liu; Richard Green; Sandra Erickson; Gregorio Gil; Michael Fuchs; Mitsuyoshi Suzuki; Tsuyoshi Murai; Hiroshi Nittono; Phillip B Hylemon; Huiping Zhou; William M Pandak
Journal:  J Lipid Res       Date:  2020-10-02       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.